Multiple cancers. Tumor burden permits the outgrowth of other cancers.
Open Access
- 1 November 1985
- journal article
- research article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 162 (5), 1665-1682
- https://doi.org/10.1084/jem.162.5.1665
Abstract
We demonstrate that tumor-bearing hosts permit the outgrowth of "potentially malignant" cells that are located at a different site. These second cancers continued to grow and kill their hosts even though they retain the "premalignant" phenotype, even after removal of the original malignancy. The potentially malignant cells used in these experiments were ultraviolet light- or methylcholanthrene-induced regressor tumor cells that are rejected regularly by normal mice at any testable dose, and only form progressive tumors in immunosuppressed individuals. The immunological rejection of these highly immunogenic, potentially malignant cells was suppressed by Thy-1+, Ly-2-, nonadherent, radiosensitive suppressor cells in the tumor-bearing mice. These suppressor cells were absent in nude tumor-bearing mice. Unlike helper and cytolytic T cell-mediated response, which are exquisitely tumor specific, the suppression caused by a progressively growing tumors induced by different carcinogens. However, T cell-mediated immune responses to alloantigens, allogeneic tumors, certain syngeneic tumors, and humoral responses to xenogeneic red blood cells were normal in these mice. The immune suppression in the tumor-bearing animals closely simulated that induced by ultraviolet light irradiation, and both types of suppression might therefore share common mechanisms. Our findings may contribute to understanding the growth, development, and possible control of multicentric malignancies and add a precaution to the potential use of strongly immunogenic tumor variants for active immunotherapy in hosts bearing less immumogenic tumors.This publication has 27 references indexed in Scilit:
- Selection of strongly immunogenic "tum-" variants from tumors at high frequency using 5-azacytidine.The Journal of Experimental Medicine, 1984
- Generation and decay of the immune response to a progressive fibrosarcoma. I. Ly-1+2- suppressor T cells down-regulate the generation of Ly-1-2+ effector T cells.The Journal of Experimental Medicine, 1984
- Multiple Primary Cancers in 5,456 Autopsy Cases in the National Cancer Center of Japan2JNCI Journal of the National Cancer Institute, 1984
- Malignant growth in the normal host after variant selection in vitro with cytolytic T-cell lines.Proceedings of the National Academy of Sciences, 1984
- Retinoblastoma: Clues to Human OncogenesisScience, 1984
- Human malignant and mitogen-transformed cells contain retroviral P15E-related antigen.The Journal of Experimental Medicine, 1984
- Roentgenographically occult lung cancer. A ten-year experience.1983
- Murine malignant cells synthesize a 19,000-dalton protein that is physicochemically and antigenically related to the immunosuppressive retroviral protein, P15E.The Journal of Experimental Medicine, 1983
- Immunoselection of tumor cell variants by mice suppressed with ultraviolet radiation.The Journal of Experimental Medicine, 1982
- Mechanisms of syngeneic tumor rejection. Susceptibility of host-selected progressor variants to various immunological effector cells.The Journal of Experimental Medicine, 1982